No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
No tracked top-trader positions in ARXS as of Oct 24, 08:13 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Financial period
Q2 2026
Adjusted EPS
Company release
Revenue
Company release
Company GAAP EPS -$0.01
EPS comparison unavailable.
Full-Year 2026 guidance
$1.96B to $1.98B
No comparable estimate
Estimates as of Oct 24, 2026
EPS expected
$0.21 to $0.34
Revenue expected
7 analysts
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $0.28 | - | $501.0M No estimate | Unavailable |
| Mar 31, 2026 | May 28, 2026 | $0.13 / $0.09Alpha Vantage | +$0.04 beat | $459.0M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $380.1M | $400.4M | $458.9M | $500.7M |
| Cost of what it sold | $217.2M | $202.8M | $224.0M | $238.1M |
| Gross profit | $162.9M | $197.6M | $234.8M | $262.6M |
| What it spent | ||||
| Sales and admin | $68.6M | $80.6M | $88.3M | $193.6M |
| Other operating costs | $251.2M | $237.0M | $36.0M | $36.3M |
| Total operating expenses | $319.9M | $317.6M | $124.3M | $229.9M |
| What was left | ||||
| Operating profit | $60.2M | $82.9M | $110.5M | $32.7M |
| Interest on debt | $68.3M | $57.4M | $44.0M | $39.4M |
| Profit before tax | -$6.8M | $29.1M | $69.0M | -$1.4M |
| Tax | — | — | $15.7M | $3.5M |
| Net profit | -$4.3M | -$29.3M | $53.3M | -$4.9M |
| EBITDA | $110.4M | $135.5M | $164.5M | $90.0M |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is neutral
Arxis Files S-1 to Register 13.35 Million Omnetics Shares for Resale Following April 2026 IPO
NeutralOct 13340,676,786 Class B Common Stock of Arxis, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2026.
NeutralOct 1332 macro signals shaping ARXS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results